Index Ventures Spins Off Biotech Investment Arm Into New Firm

  • Medicxi Ventures will have $750 million under management
  • Firm closes new early-stage biotech fund with Glaxo, J&J

Index Ventures, best known for funding startups like Skype and the creator of the Candy Crush Saga online game, is spinning off its biotechnology investments into a new venture-capital firm.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.